Table of Contents Global Hemoglobinopathies Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Hemoglobinopathies Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Hemoglobinopathies Segment by Type 1.2.1 Blood Transfusion 1.2.2 Iron Chelation Therapy 1.2.3 Bone Marrow Transplant 1.2.4 Others 1.3 Market Analysis by Application 1.3.1 Blood Testing 1.3.2 Genetic Testing 1.3.3 Pre-Implantation Genetic Diagnosis (PGD) 1.3.4 Others 1.4 Overview of Global Hemoglobinopathies Market 1.4.1 Global Hemoglobinopathies Revenue (2015-2025) 1.4.2 Global Hemoglobinopathies Production and Capacity (2015-2025) 1.4.3 North America Hemoglobinopathies Status and Prospect (2015-2025) 1.4.4 Europe Hemoglobinopathies Status and Prospect (2015-2025) 1.4.5 Japan Hemoglobinopathies Status and Prospect (2014-2025) 1.4.6 China Hemoglobinopathies Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Hemoglobinopathies Industry Impact 1.6.1 How the Covid-19 is Affecting the Hemoglobinopathies Industry 1.6.2 Hemoglobinopathies Business Impact Assessment - Covid-19 1.6.3 Market Trends and Hemoglobinopathies Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Hemoglobinopathies Market Competition by Manufacturer 2.1 Global Hemoglobinopathies Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Hemoglobinopathies Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Hemoglobinopathies Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Hemoglobinopathies Manufacturer Market Share 2.5 Top 10 Hemoglobinopathies Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Hemoglobinopathies Market 2.7 Key Manufacturers Hemoglobinopathies Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Hemoglobinopathies Industry Key Manufacturers 3.1 Gamida Cell 3.1.1 Company Details 3.1.2 Product Information 3.1.3 Gamida Cell Hemoglobinopathies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 Gamida Cell News 3.2 Alnylam Pharmaceuticals 3.2.1 Company Details 3.2.2 Product Information 3.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 Alnylam Pharmaceuticals News 3.3 Sanofi 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Sanofi Hemoglobinopathies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Sanofi News 3.4 Sangamo Therapeutics Inc. 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Sangamo Therapeutics Inc. Hemoglobinopathies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Sangamo Therapeutics Inc. News 3.5 Global Blood Therapeutics 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Global Blood Therapeutics Hemoglobinopathies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Global Blood Therapeutics News 3.6 Bluebird Bio 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Bluebird Bio Hemoglobinopathies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Bluebird Bio News 3.7 Emmaus Life Sciences Inc. 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Emmaus Life Sciences Inc. Hemoglobinopathies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Emmaus Life Sciences Inc. News 3.8 Prolong Pharmaceuticals 3.8.1 Company Details 3.8.2 Product Information 3.8.3 Prolong Pharmaceuticals Hemoglobinopathies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 Prolong Pharmaceuticals News 3.9 Celgene Corporation 3.9.1 Company Details 3.9.2 Product Information 3.9.3 Celgene Corporation Hemoglobinopathies Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.9.4 Main Business Overview 3.9.5 Celgene Corporation News 4 Global Hemoglobinopathies Market Size Categorized by Regions (2015-2020) 4.1 Global Hemoglobinopathies Sales Market Share by Region 4.2 Global Hemoglobinopathies Revenue Market Share by Region (2015-2019) 4.3 Global Hemoglobinopathies Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Hemoglobinopathies Market Size Detail 4.4.1 North America Hemoglobinopathies Sales Growth Rate (2015-2020) 4.4.2 North America Hemoglobinopathies Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Hemoglobinopathies Market Size Detail 4.5.1 Europe Hemoglobinopathies Sales Growth Rate (2015-2020) 4.5.2 Europe Hemoglobinopathies Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Hemoglobinopathies Market Size Detail 4.6.1 Japan Hemoglobinopathies Sales Growth Rate (2015-2020) 4.6.2 Japan Hemoglobinopathies Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Hemoglobinopathies Market Size Detail 4.7.1 China Hemoglobinopathies Sales Growth Rate (2015-2020) 4.7.2 China Hemoglobinopathies Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Hemoglobinopathies Market Segment by Type 5.1 Global Hemoglobinopathies Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Hemoglobinopathies Sales and Market Share by Type (2015-2020) 5.1.2 Global Hemoglobinopathies Revenue and Market Share by Type (2015-2020) 5.2 Blood Transfusion Sales Growth Rate and Price 5.2.1 Global Blood Transfusion Sales Growth Rate (2015-2020) 5.2.2 Global Blood Transfusion Price (2015-2020) 5.3 Iron Chelation Therapy Sales Growth Rate and Price 5.3.1 Global Iron Chelation Therapy Sales Growth Rate (2015-2020) 5.3.2 Global Iron Chelation Therapy Price (2015-2020) 5.4 Bone Marrow Transplant Sales Growth Rate and Price 5.4.1 Global Bone Marrow Transplant Sales Growth Rate (2015-2020) 5.4.2 Global Bone Marrow Transplant Price (2015-2020) 5.5 Others Sales Growth Rate and Price 5.5.1 Global Others Sales Growth Rate (2015-2020) 5.5.2 Global Others Price (2015-2020) 6 Global Hemoglobinopathies Market Segment by Application 6.1 Global Hemoglobinopathies Sales Market Share by Application (2015-2020) 6.2 Blood Testing Sales Growth Rate (2015-2020) 6.3 Genetic Testing Sales Growth Rate (2015-2020) 6.4 Pre-Implantation Genetic Diagnosis (PGD) Sales Growth Rate (2015-2020) 6.5 Others Sales Growth Rate (2015-2020) 7 Hemoglobinopathies Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Hemoglobinopathies Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Hemoglobinopathies Market Forecast 8.1 Global Hemoglobinopathies Sales, Revenue Forecast 8.1.1 Global Hemoglobinopathies Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Hemoglobinopathies Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Hemoglobinopathies Price and Trend Forecast (2020-2025) 8.2 Global Hemoglobinopathies Sales Forecast by Region (2020-2025) 8.2.1 North America Hemoglobinopathies Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Hemoglobinopathies Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Hemoglobinopathies Production, Revenue Forecast (2020-2025) 8.2.4 China Hemoglobinopathies Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Hemoglobinopathies Picture Table Global Hemoglobinopathies Sales by Type Figure Global Sales Market Share of Hemoglobinopathies by Product Type in 2019 Table Breakdown of Hemoglobinopathies by Company Type (Tier 1, Tier 2 and Tier 3) Figure Hemoglobinopathies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Blood Transfusion Picture Figure Iron Chelation Therapy Picture Figure Bone Marrow Transplant Picture Figure Others Picture Table Global Hemoglobinopathies Sales by Application Figure Global Hemoglobinopathies Sales Market Share by Application in 2019 Figure Blood Testing Picture Figure Genetic Testing Picture Figure Pre-Implantation Genetic Diagnosis (PGD) Picture Figure Others Picture Table Hemoglobinopathies Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Hemoglobinopathies Revenue (Million US$) (2015-2025) Figure Global Hemoglobinopathies Production (K Units) (2015-2025) Figure North America Hemoglobinopathies Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Hemoglobinopathies Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Hemoglobinopathies Revenue (Million US$) Growth Rate (2014-2025) Figure China Hemoglobinopathies Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Hemoglobinopathies Sales by Manufacturer (2018-2020) Figure Global Hemoglobinopathies Sales Market Share by Manufacturer in 2019 Table Global Hemoglobinopathies Revenue by Manufacturer (2018-2020) Figure Global Hemoglobinopathies Revenue Market Share by Manufacturer in 2019 Table Global Hemoglobinopathies Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Hemoglobinopathies Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Hemoglobinopathies Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Hemoglobinopathies Market Table Key Manufacturers Hemoglobinopathies Product Type Table Mergers & Acquisitions Planning Table Gamida Cell Company Profile Figure Hemoglobinopathies Product Picture and Specifications of Gamida Cell Table Hemoglobinopathies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Gamida Cell Hemoglobinopathies Market Share (2018-2020) Table Gamida Cell Main Business Table Gamida Cell Recent Development Table Alnylam Pharmaceuticals Company Profile Figure Hemoglobinopathies Product Picture and Specifications of Alnylam Pharmaceuticals Table Hemoglobinopathies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Alnylam Pharmaceuticals Hemoglobinopathies Market Share (2018-2020) Table Alnylam Pharmaceuticals Main Business Table Alnylam Pharmaceuticals Recent Development Table Sanofi Company Profile Figure Hemoglobinopathies Product Picture and Specifications of Sanofi Table Hemoglobinopathies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Sanofi Hemoglobinopathies Market Share (2018-2020) Table Sanofi Main Business Table Sanofi Recent Development Table Sangamo Therapeutics Inc. Company Profile Figure Hemoglobinopathies Product Picture and Specifications of Sangamo Therapeutics Inc. Table Hemoglobinopathies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Sangamo Therapeutics Inc. Hemoglobinopathies Market Share (2018-2020) Table Sangamo Therapeutics Inc. Main Business Table Sangamo Therapeutics Inc. Recent Development Table Global Blood Therapeutics Company Profile Figure Hemoglobinopathies Product Picture and Specifications of Global Blood Therapeutics Table Hemoglobinopathies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Global Blood Therapeutics Hemoglobinopathies Market Share (2018-2020) Table Global Blood Therapeutics Main Business Table Global Blood Therapeutics Recent Development Table Bluebird Bio Company Profile Figure Hemoglobinopathies Product Picture and Specifications of Bluebird Bio Table Hemoglobinopathies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bluebird Bio Hemoglobinopathies Market Share (2018-2020) Table Bluebird Bio Main Business Table Bluebird Bio Recent Development Table Emmaus Life Sciences Inc. Company Profile Figure Hemoglobinopathies Product Picture and Specifications of Emmaus Life Sciences Inc. Table Hemoglobinopathies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Emmaus Life Sciences Inc. Hemoglobinopathies Market Share (2018-2020) Table Emmaus Life Sciences Inc. Main Business Table Emmaus Life Sciences Inc. Recent Development Table Prolong Pharmaceuticals Company Profile Figure Hemoglobinopathies Product Picture and Specifications of Prolong Pharmaceuticals Table Hemoglobinopathies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Prolong Pharmaceuticals Hemoglobinopathies Market Share (2018-2020) Table Prolong Pharmaceuticals Main Business Table Prolong Pharmaceuticals Recent Development Table Celgene Corporation Company Profile Figure Hemoglobinopathies Product Picture and Specifications of Celgene Corporation Table Hemoglobinopathies Production, Price, Revenue and Gross Margin of 2018-2020 Figure Celgene Corporation Hemoglobinopathies Market Share (2018-2020) Table Celgene Corporation Main Business Table Celgene Corporation Recent Development Table Global Hemoglobinopathies Sales (K Units) by Region (2015-2020) Table Global Hemoglobinopathies Sales Market Share by Region (2015-2019) Figure Global Hemoglobinopathies Sales Market Share by Region (2015-2019) Figure Global Hemoglobinopathies Sales Market Share by Region in 2018 Table Global Hemoglobinopathies Revenue (Million US$) by Region (2015-2020) Table Global Hemoglobinopathies Revenue Market Share by Region (2015-2020) Figure Global Hemoglobinopathies Revenue Market Share by Region (2015-2020) Figure Global Hemoglobinopathies Revenue Market Share by Region in 2019 Table Global Hemoglobinopathies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Hemoglobinopathies Sales (K Units) Growth Rate (2015-2020) Figure Europe Hemoglobinopathies Sales (K Units) Growth Rate (2015-2020) Table Europe Hemoglobinopathies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Hemoglobinopathies Sales (K Units) Growth Rate (2015-2020) Table Japan Hemoglobinopathies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Hemoglobinopathies Sales (K Units) Growth Rate (2015-2020) Table China Hemoglobinopathies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Hemoglobinopathies Sales by Type (2015-2020) Table Global Hemoglobinopathies Sales Market Share by Type (2015-2020) Figure Global Hemoglobinopathies Sales Market Share by Type in 2019 Table Global Hemoglobinopathies Revenue by Type (2015-2020) Table Global Hemoglobinopathies Revenue Market Share by Type (2015-2020) Figure Global Hemoglobinopathies Revenue Market Share by Type in 2019 Figure Global Blood Transfusion Sales Growth Rate (2015-2025) Figure Global Blood Transfusion Price (2015-2020) Figure Global Iron Chelation Therapy Sales Growth Rate (2015-2025) Figure Global Iron Chelation Therapy Price (2015-2020) Figure Global Bone Marrow Transplant Sales Growth Rate (2015-2025) Figure Global Bone Marrow Transplant Price (2015-2020) Figure Global Others Sales Growth Rate (2015-2025) Figure Global Others Price (2015-2020) Table Global Hemoglobinopathies Sales Market Share by Application (2015-2020) Figure Global Hemoglobinopathies Sales Market Share by Application in 2019 Figure Global Blood Testing Sales Growth Rate (2015-2025) Figure Global Genetic Testing Sales Growth Rate (2015-2025) Figure Global Pre-Implantation Genetic Diagnosis (PGD) Sales Growth Rate (2015-2025) Figure Global Others Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Hemoglobinopathies Table Key Players of Downstream Markets Figure Sales Channel Figure Global Hemoglobinopathies Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Hemoglobinopathies Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Hemoglobinopathies Price and Trend Forecast (2020-2025) Table Global Hemoglobinopathies Sales (K Units) Forecast by Region (2020-2025) Figure Global Hemoglobinopathies Production Market Share Forecast by Region (2020-2025) Figure North America Hemoglobinopathies Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Hemoglobinopathies Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Hemoglobinopathies Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Hemoglobinopathies Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Hemoglobinopathies Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Hemoglobinopathies Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Hemoglobinopathies Production (K Units) Growth Rate Forecast (2020-2025) Figure China Hemoglobinopathies Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Gamida Cell Alnylam Pharmaceuticals Sanofi Sangamo Therapeutics Inc. Global Blood Therapeutics Bluebird Bio Emmaus Life Sciences Inc.